台股 » 個股 » 東生華 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

東生華

(8432)
可現股當沖
  • 股價
    59.0
  • 漲跌
    ▲0.1
  • 漲幅
    +0.17%
  • 成交量
    76
  • 產業
    上櫃 生技醫療類股
  • 36人加入追蹤

    立即追蹤

  • 本地時間:13:30

     
東生華 (8432)籌碼相關-宏遠 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

宏遠 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2024/09/1000.00355.5055.60-3162-1.84%
2024/09/061058.1600.0057.00101636.11%
2024/09/0300.00959.2058.60-9169-5.32%
2024/08/2700.00860.0959.70-8177-4.52%
2024/08/21158.7000.0058.2011770.56%
2024/08/0900.00156.4056.20-1203-0.49%
2024/08/08156.4000.0056.2012010.50%
2024/08/062359.17655.5359.40171988.56%
2024/07/0400.001067.6667.80-10223-4.48%
2024/07/0100.00668.6068.50-6226-2.65%
2024/06/061166.0300.0067.10112175.07%
2024/06/0500.00563.2064.00-5212-2.36%
2024/06/0400.00364.3063.30-3214-1.40%
2024/05/2300.00462.4362.50-4269-1.48%
2024/05/071763.7100.0062.30172845.98%
2023/11/0800.00357.5756.40-3278-1.08%
2023/09/1500.00245.4045.70-274-2.67%
2023/07/2500.00147.1547.60-172-1.38%
2023/07/1900.00450.0049.85-462-6.38%
2023/07/18446.7100.0047.054488.29%
2023/05/03145.9500.0046.101571.74%
2023/03/13246.7000.0046.702712.80%
2022/09/0500.00351.5349.00-3254-1.18%
2022/07/25246.70247.9047.950800.00%
2021/05/11142.3500.0042.2011280.78%
2021/04/29246.6500.0046.0021151.74%
2020/12/24159.2000.0059.701571.75%
2020/11/2500.00160.4060.00-153-1.88%
2020/11/19159.0000.0060.001551.80%
2020/11/11162.1000.0062.301492.04%
2020/11/02162.9000.0062.101501.98%
2020/07/1300.00168.8069.20-1109-0.92%
2020/06/18168.8000.0068.701701.41%
2020/01/3100.00179.0078.70-127-3.66%
2019/11/22180.0000.0080.301224.48%
2019/07/2900.00171.7071.40-128-3.49%
2019/05/0800.00165.9065.80-156-1.78%
2019/04/15166.0000.0066.101691.45%
2019/02/15169.1000.0069.101501.97%
2019/01/30166.0000.0065.901482.05%
2018/07/2500.00183.1082.20-1148-0.67%
2018/07/24182.5000.0081.7011550.64%
2018/07/2000.00180.3081.10-1198-0.50%
2018/07/1300.00182.4082.70-1345-0.29%
2018/07/09283.5000.0083.4023910.51%
2018/07/0500.00180.3079.70-1390-0.26%
2018/06/21177.9000.0077.5014240.24%
2018/05/0400.00271.5071.00-2431-0.46%
2018/05/02177.2000.0075.1014240.24%
2018/04/27180.8000.0080.1014220.24%
2018/04/261489.241491.2789.0004090.00%
2018/04/1900.00187.5086.90-1266-0.38%
2018/04/0300.00177.5075.40-1187-0.53%
2018/03/12170.2000.0070.0011500.66%
2018/03/0900.00174.0071.70-1149-0.67%
2018/02/08171.7000.0071.2011320.76%
2018/02/0200.00172.5074.80-1122-0.82%
2018/01/3000.00171.4071.00-1112-0.89%
2018/01/24168.50171.0068.9001050.00%
2018/01/22168.70170.0068.700950.00%
2018/01/19166.8000.0066.801901.11%
2018/01/1800.00167.3065.90-186-1.16%
2018/01/17165.6000.0065.101771.28%
2018/01/1600.00167.0067.10-175-1.33%
2018/01/1100.00161.2061.00-161-1.64%
2018/01/08156.8000.0056.801581.71%
東生華液態切片技術新突破 成功識別92%肺癌基因突變Anue鉅亨-2024/08/26
東生華攜手陽明交大簽署MOU 聚焦人才培育、精準藥物開發Anue鉅亨-2024/07/22
東生華法說會/併購高峰、三大業務加持 今年營收拚增五成達12億UDN聯合新聞網-2024/03/25
東生華 相關文章